ÃÛÌÒ´«Ã½

Good morning, trader! Let’s start off the day right with a look into the biggest pre-market stock movers for Thursday!

Source: ventdusud / Shutterstock.com

Loads of penny stocks are on the move today and we’re also seeing other shares in the news for patent news, CEO changes, clinical trials, and more.

Now to jump into that news!

Pre-ÃÛÌÒ´«Ã½ Stock Movers: 10 Top Gainers

1. Kaival Brands Innovations (NASDAQ:KAVL) stock is rocketing more than 39% on heavy trading and no news.
2. Alterity Therapeutics (NASDAQ:ATHE) shares are soaring over 37%
3. Siyata Mobile (NASDAQ:SYTA) stock is surging more than 20% despite a lack of news this morning.
4. TherapeuticsMD (NASDAQ:TXMD) shares are increasing over 9% as it recovers from a dip on Wednesday.
5. Chembio Diagnostics (NASDAQ:CEMI) stock is gaining nearly 9% .
6. My Size (NASDAQ:MYSZ) shares are climbing more than 8% .
7. Largo (NASDAQ:LGO) stock is getting an over 8% boost on no apparent news this morning.
8. Spruce Biosciences (NASDAQ:SPRB) shares are rising close to 8% .
9. Aurora Mobile (NASDAQ:JG) stock is jumping almost 6% higher on no news to speak of.
10. ObsEva (NASDAQ:OBSV) shares are up more than 5% .

10 Top Losers

1. Berkeley Lights (NASDAQ:BLI) stock is plummeting almost 30% .
2. CNS Pharmaceuticals (NASDAQ:CNSP) shares are taking a roughly 14% beating .
3. ATA Creativity Global (NASDAQ:AACG) stock is diving over 11% as shares pull back from a recent rally.
4. Microvision (NASDAQ:MVIS) shares are dropping more than 10% .
5. Vertical Aerospace (NYSE:EVTL) stock is heading over 9% lower following a surprise rally yesterday.
6. Sino-Global Shipping (NASDAQ:SINO) shares are decreasing more than 9% .
7. NLS Pharmaceutics (NASDAQ:NLSP) stock is sitting over 9% lower .
8. Ebang International (NASDAQ:EBON) shares are dipping nearly 8% after shares rallied higher on Wednesday.
9. Plus Therapeutics (NASDAQ:PSTV) stock is slipping more than 7% .
10. Lixte Biotech Holdings (NASDAQ:LIXTW) shares close out our pre-market stock movers down over 7% .

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.